January is Radon Action Month and Colorado public health officials said now is the best time to test your home.
Low testosterone manifests itself in a several different ways, from low libido to erectile dysfunction – but there are ways ...
Revvity aims to expand the FDA-cleared menu for the EUROIMMUN family of ChLIA automation solutions to serve a wider patient pool.
The chemiluminescence-based immunoassay is used for the direct quantitative measurement of free testosterone in serum or plasma, with results in 48 minutes.
"Revvity wins FDA clearance for ChLIA assay in free testosterone measurement" was originally created and published by Medical ...
Revvity (RVTY) received 510(k) clearance from FDA for EUROIMMUN's automated chemiluminescence-based immunoassay test for free ...
Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA ...